Investor Day POLYONE I N V E S T O R P R E S E N T A T I O N M A R C H 2 0 1 8 FORWARD LOOKING STATEMENTS PolyOne Corporation 2 In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. T H E N E W P O L Y O N E : A S P E C I A L T Y G R O W T H C O M P A N Y  Growing leadership position in attractive markets  Innovation, technology and service are differentiators  Capital management is a strength: Record-setting cash generation to continue for years  Expand ROIC while increasing invested capital  Proven acquisition strategy with robust pipeline  Commercial investments are fueling momentum and generating organic growth SEGMENT HIGHLIGHTS PolyOne Corporation 17 C O L O R , A D D I T I V E S & I N K S PolyOne Corporation 18 Solid Colorants Performance Additives Screen Printing Inks Liquid Colorants 27% 14% Textiles Building & Electrical & Operating Income & MarginRevenue by Region C O L O R , A D D I T I V E S & I N K S 2 0 1 7 R E V E N U E | $ 8 9 3 M I L L I O N $4 $25 $104 $139 0.9% 5.5% 12.2% 15.5% 16.0% 18.0% 100 110 120 130 140 150 PolyOne Corporation 19 32% 46% 1% Mexico Brazil S P E C I A L T Y E N G I N E E R E D M A T E R I A L S PolyOne Corporation 20 Engineered Formulations Advanced Composites Thermoplastic Elastomers 20% 19% Electrical & 13% Building & S P E C I A L T Y E N G I N E E R E D M A T E R I A L S Revenue by Region Operating Income & Margin 2 0 1 7 R E V E N U E | $ 6 2 4 M I L L I O N PolyOne Corporation 21 $21 $57 $78 0.1% 5.1% 9.3% 12.5% 28% 48% 22% P E R F O R M A N C E P R O D U C T S & S O L U T I O N S PolyOne Corporation 22 Specialty Vinyl Solutions Healthcare Formulations Smart Device Materials Flame Retardant Polymers Building & 30% 15%Appliance Electrical & 1% Mexico 77% Latin America P E R F O R M A N C E P R O D U C T S & S O L U T I O N S Operating Income & MarginRevenue by Region 2 0 1 7 R E V E N U E | $ 7 2 1 M I L L I O N $40 $33 $56 $77 4.6% 3.6% 7.2% 10.7% 16.0% 0 100 PolyOne Corporation 23 D I S T R I B U T I O N E N D M A R K E T S & S U P P L I E R S PolyOne Corporation 24 23% Healthcare 22% Electrical & Building & $20 $25 $63 $73 2.9% 5.9% 6.3% 1.0% 3.0% 5.0% 7.0% 15 25 35 45 55 65 75 Operating Income & Margin 2017 Revenue | $1.2 Billion http://www.polyone.com/Pages/VariationRoot.aspx http://www.polyone.com/Pages/VariationRoot.aspx T A R G E T E N D M A R K E T S & A P P L I C A T I O N E X A M P L E S PolyOne Corporation 25 Thermally Conductive Chemical Resistant Polymer Colorants Elastomeric Grips and Handles Structural Composites Antimicrobial Technologies Anti-Counterfeiting Target End Markets… Healthcare Catheter Technologies Under-hood Components Target End Markets… Automotive Interior Structural Sound & Vibration Management Roof Systems Air Management Electronics and Cameras Lighting Exterior / Interior Trim Braces & Brackets Fasteners Seals & Flaps Target End Markets… Consumer Thermally Conductive Polymer Colorants Elastomeric Grips and Handles Structural Composite Oxygen Scavenger Laser Marking Additives Antistatic Technologies UV Light Barrier Technologies Cap & Closure Colorants Process Optimization Antioxidant Technologies Density Modified Target End Markets… Packaging  Impart weight, sound and metallic finish to caps and closures for cosmetics and spirits applications  Elevate quality and prestige perceptions among high-end consumers  Eliminate time and cost associated with secondary operations and assembly Luxury Packaging GravitechTM Density Modified Polymers  Eliminate costs by increasing pigment density  Enhance color performance without altering form and formulation  Increase design capabilities by reducing weight and layer thickness Optimize Color Usage OnColorTM Super Concentrates  Inhibit microbial growth on polymer surfaces  Enhance value or products and devices  Highly versatile concentrate with the ability to be incorporated into a wide variety of products Combat Bacteria Formation WithStandTM Antimicrobial Technology  Durable, long-lasting products stand up to the most aggressive disinfectants  Minimize environmental stress cracking and discoloration  One of the broadest medically approved polymer and colorant portfolios Medical Device Housings Chemically Resistant Engineered Polymers Color & Design Services  Greater control of color development and supply chain  Work across entire design process from concept to commercialization  Inspire creativity in the use of polymer materials, colors, and effects  Innovative brand differentiation  Faster development timelines Outdoor Applications  Leading provider of high performance specialty materials for the recreational and sports & leisure industry  Well positioned across all segments to address market needs  Metal to Polymer Conversion  Lightweighting  Thermal Management  Impact Performance  ColorMatrix Fiber Colorant Solutions  Proprietary advanced liquid color formulations and equipment enable greater efficiency and productivity  Eliminates aqueous dyeing and its associated wastewater treatment  Solid Color Concentrates  Extrusion-spun fibers colored via solid masterbatch Fiber Colorants  High flame retardancy to meet strict UL standards  Greater processing and design flexibility  Specialized additives provide long term color stability  Diffusive lens materials improve light dispersion Smart Home Devices ResilienceTM Vinyl Solutions 1 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne common shareholders, adjusted earnings per share (EPS) attributable to PolyOne common shareholders and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance. Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016 2017 Net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — — — Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation

MAGATARTÁSI KÓDEXÜNK | 27 MAGATARTÁSI A TISZTELET BECSÜLETESSÉG A ÜZLETI TÁRSADALMI https://www.avient.com/company/sustainability/sustainability-report http://Avient.com/sustainability http://Avient.com/sustainability https://www.avient.com/company/sustainability/sustainability-report/products/no-surprises-pledge-0 K: A felettesem arra kért, hogy alkalmazzak egy új hulladékkezelési eljárást, de nem vagyok biztos abban, hogy ez biztonságos vagy egyáltalán törvényes-e. avient.ethicspoint.com 1-877-228-5410 (USA). MAGATARTÁSI A TISZTELET BECSÜLETESSÉG A ÜZLETI TÁRSADALMI MAGATARTÁSI KÓDEXÜNK | 30 http://avient.ethicspoint.com Észak-Amerika Globális Központ Avon Lake, Egyesült Államok 33587 Walker Road Avon Lake, OH, Egyesült Államok 44012 Ingyenesen hívható telefonszám: +1 866 765 9663 Telefon: +1 440 930 1000 Fax: +1 440 930 3064 Ázsia és a Csendes-óceáni térség Regionális Központ Sanghaj, Kína 2F, Block C 200 Jinsu Road Pudong, 201206 Sanghaj, Kína Telefonszám: +86 (0) 21 6028 4888 Fax: +86 (0) 21 6028 4999 Dél-Amerika Regionális központ São Paulo, Brazília Av.

PolyOne Corporation Page 1 PolyOne Investor Presentation Goldman Sachs Basic Materials Conference May 2016 PolyOne Corporation Page 2 Forward-Looking Statements  In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Adjusted EPS is calculated as follows: Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014Y 2015Y Net income (loss) attributable to PolyOne common shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 Joint venture equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) - - - - Special items, after tax(1) (51.2) 10.7 457.2 (75.9) (72.5) (72.8) 36.2 32.6 90.5 28.9 Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 93.5 88.7 Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 Adjusted EPS Q1 2009* Q2 2009* Q3 2009* Q4 2009* Q1 2010 Q2 2010 Q3 2010 Q4 2010 Net income attributable to PolyOne common shareholders $ 3.3 $ 1.3 $ 51.3 $ 50.8 $ 20.1 $ 44.7 $ 0.1 $ 87.6 Joint venture equity earnings, after tax (8.2) (5.8) (3.0) (2.0) (0.5) (4.5) (6.2) (3.5) Special items, after tax(1) (10.2) 9.2 (36.9) (38.0) (3.8) (22.1) 25.4 (72.0) Adjusted net (loss) income $ (15.1) $ 4.7 $ 11.4 $ 10.8 $ 15.8 $ 18.1 $ 19.3 $ 12.1 Diluted shares 92.2 93.5 93.9 94.4 95.3 96.3 96.3 97.4 Adjusted EPS $ (0.16) $ 0.05 $ 0.12 $ 0.11 $ 0.17 $ 0.19 $ 0.20 $ 0.12 Adjusted EPS Q1 2011 Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Net income attributable to PolyOne common shareholders $ 106.0 $ 23.1 $ 16.0 $ 8.3 $ 15.3 $ 18.4 $ 19.4 $ 0.2 Joint venture equity earnings, after tax (3.7) - - - - - - - Special items, after tax(1) (81.3) 1.3 2.8 4.4 6.2 8.9 5.4 15.7 Adjusted net income $ 21.0 $ 24.4 $ 18.8 $ 12.7 $ 21.5 $ 27.3 $ 24.8 $ 15.9 Diluted shares 96.4 95.5 94.0 91.9 90.7 90.7 90.2 90.5 Adjusted EPS $ 0.22 $ 0.26 $ 0.20 $ 0.14 $ 0.24 $ 0.30 $ 0.28 $ 0.18 2 Adjusted EPS Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Net income (loss) attributable to PolyOne common shareholders $ 11.2 $ 38.6 $ 23.2 $ 21.0 $ 29.4 $ 30.9 $ 32.3 $ (14.6) Special items, after tax(1) 17.7 (2.0) 12.3 4.6 12.5 17.4 13.1 47.5 Adjusted net income $ 28.9 $ 36.6 $ 35.5 $ 25.6 $ 41.9 $ 48.3 $ 45.4 $ 32.9 Diluted shares 92.8 99.1 98.1 97.2 95.7 94.3 93.1 91.3 Adjusted EPS $ 0.31 $ 0.37 $ 0.36 $ 0.26 $ 0.44 $ 0.51 $ 0.49 $ 0.36 Adjusted EPS Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Net income attributable to PolyOne common shareholders $ 30.2 $ 66.8 $ 44.5 $ 3.1 $ 39.1 Special items, after tax(1) 11.4 (15.9) 3.0 30.4 9.1 Adjusted net income $ 41.6 $ 50.9 $ 47.5 $ 33.5 $ 48.2 Diluted shares 90.1 89.8 88.4 86.6 85.5 Adjusted EPS $ 0.46 $ 0.57 $ 0.54 $ 0.39 $ 0.56 Adjusted operating margin is calculated as follows: Adjusted operating margin Q1 2009* Q2 2009* Q3 2009* Q4 2009* YTD 2009* Q1 2010 Q2 2010 Q3 2010 Q4 2010 YTD 2010 Operating Income $ 9.9 $ 17.1 $ 57.9 $ 52.2 $ 137.1 $ 32.3 $ 58.6 $ 42.0 $ 26.3 $ 159.2 Special items (1) (1.3) 4.6 (27.5) (24.5) (48.7) - (14.5) 5.5 4.2 (4.8) Joint venture equity earnings (12.8) (9.0) (4.8) (3.1) (29.7) (0.8) (7.1) (9.7) (5.5) (23.1) Adjusted operating (loss) income $ (4.2) $ 12.7 $ 25.6 $ 24.6 $ 58.7 $ 31.5 $ 37.0 $ 37.8 $ 25.0 $ 131.3 Sales $ 463.4 $ 496.5 $ 548.3 $ 552.5 $ 2,060.7 $ 604.0 $ 666.2 $ 650.7 $ 585.3 $ 2,506.2 Operating Margin (0.9)% 2.6% 4.7% 4.5% 2.8% 5.2% 5.6% 5.8% 4.3% 5.2% Adjusted operating margin Q1 2011 Q2 2011 Q3 2011 Q4 2011 YTD 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 YTD 2012 Operating income (loss) $ 173.4 $ 42.4 $ 33.4 $ (46.2) $ 203.0 $ 37.4 $ 43.3 $ 43.5 $ 13.3 $ 137.5 Special items (1) (127.2) 2.7 4.9 72.9 (46.7) 8.5 11.8 8.3 25.3 53.9 Joint venture equity earnings (5.7) - - - (5.7) - - - - - Adjusted operating income $ 40.5 $ 45.1 $ 38.3 $ 26.7 $ 150.6 $ 45.9 $ 55.1 $ 51.8 $ 38.6 $ 191.4 Sales $ 682.8 $ 723.4 $ 694.0 $ 609.2 $ 2,709.4 $ 745.5 $ 756.6 $ 707.7 $ 651.0 $ 2,860.8 Operating Margin 5.9% 6.2% 5.5% 4.4% 5.6% 6.2% 7.3% 7.3% 5.9% 6.7% 3 Adjusted operating margin Q1 2013 Q2 2013 Q3 2013 Q4 2013 YTD 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 YTD 2014 Operating income (loss) $ 40.5 $ 80.7 $ 61.6 $ 48.7 $ 231.5 $ 56.4 $ 49.4 $ 63.6 $ (14.3) $ 155.1 Special items (1) 16.6 (5.2) 10.8 7.8 30.0 22.9 39.8 22.0 80.2 164.9 Adjusted operating income $ 57.1 $ 75.5 $ 72.4 $ 56.5 $ 261.5 $ 79.3 $ 89.2 $ 85.6 $ 65.9 $ 320.0 Sales $ 801.1 $ 1,037.6 $ 1,008.9 $ 923.6 $ 3,771.2 $ 1,002.3 $ 1,005.5 $ 958.4 $ 869.3 $ 3,835.5 Operating Margin 7.1% 7.3% 7.2% 6.1% 6.9% 7.9% 8.9% 8.9% 7.6% 8.3% Adjusted operating margin Q1 2015 Q2 2015 Q3 2015 Q4 2015 YTD 2015 Q1 2016 Operating income $ 70.1 $ 80.3 $ 69.2 $ 31.3 $ 250.9 $ 71.3 Special items (1) 9.3 11.9 18.7 31.4 71.3 13.8 Adjusted operating income $ 79.4 $ 92.2 $ 87.9 $ 62.7 $ 322.2 $ 85.1 Sales $ 873.1 $ 887.1 $ 841.6 $ 775.8 $ 3,377.6 $ 847.0 Operating Margin 9.1% 10.4% 10.4% 8.1% 9.5% 10.0% Adjusted gross margin is calculated as follows: (In millions) Twelve Months Ended December 31, 2015 Gross margin - GAAP $ 681.5 Special items in gross margin(1) 39.7 Gross margin before special items $ 721.2 Specialty operating income mix percentage is calculated as follows: Platform operating income mix percentage 2005* 2010* 2015 Color, Additives and Inks $ 4.3 $ 37.7 $ 135.4 Specialty Engineered Materials 0.4 49.7 79.6 Designed Structures and Solutions - - 13.8 Specialty Platform $ 4.7 $ 87.4 $ 228.8 Performance Products and Solutions 75.7 54.0 57.4 Distribution 19.5 42.0 68.0 Joint ventures 91.9 18.9 — Corporate and eliminations (51.5) (27.7) (103.3) Operating income GAAP $ 140.3 $ 174.6 $ 250.9 Less: Corporate operating expense 51.5 27.7 103.3 Operating income excluding Corporate $ 191.8 $ 202.3 $ 354.2 Specialty platform operating mix percentage 2% 43% 65% 4 Adjusted EBITDA and net debt to adjusted EBITDA is calculated as follows: (In millions) Q2 2015 Q3 2015 Q4 2015 Q1 2016 Trailing Twelve Months Ended March 31, 2016 Income (loss) from continuing operations, before income taxes $ 63.4 $ 51.4 $ (0.4) $ 57.0 $ 171.4 Interest expense, net 16.2 16.2 15.6 14.6 62.6 Depreciation and amortization 25.0 28.3 25.9 27.2 106.4 Special items, impact on income (loss) from continuing operations before income taxes(1) 11.9 18.6 47.8 13.6 91.9 Accelerated depreciation included in special items (0.2) (4.3) (1.6) (2.8) (8.9) Adjusted EBITDA $ 116.3 $ 110.2 $ 87.3 $ 109.6 $ 423.4 Short-term and current portion of long-term debt $ 18.6 Long-term debt 1,174.3 Less: Cash and cash equivalents (155.4) Net Debt 1,037.5 Net Debt/TTM Adjusted EBITDA 2.5 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal, discontinued operations or the related resegmentation 1) Special items are a non-GAAP financial measure and are used to determine adjusted earnings.

مدونة قواعد السلوك مدونة قواعد السلوك الخاصة | 17 http://polynet/ethics/CorporatePolicies/InformationSystemsUsePolicies/tabid/1885/Default.aspx http://polynet/ethics/CorporatePolicies/CyberandDataIncidentResponsePolicy/tabid/2729/Default.aspx http://polynet/ethics/GlobalPrivacyandDataProtectionPolicies/tabid/1870/Default.aspx http://polynet/ethics/CorporatePolicies/InformationSystemsUsePolicies/tabid/1885/Default.aspx http://polynet/ethics/CorporatePolicies/CyberandDataIncidentResponsePolicy/tabid/2729/Default.aspx المعلومات الداخلية والتداول قد تُتُاح لك الفرصة في Avient للاطلاع على معلومات جوهرية تخص الشركة أو أي شركة أخرى تربطنا بها تعاملات تجارية لم يتم الإفصاح عنها للعامة. اتبع هاتيْنْ القاعدتيْنْ البسيطتيْنْ: 1 لا تستخدم معلومات جوهرية غير مخصصة للعامة لتحقيق مكاسب . مدونة قواعد السلوك المسؤولية الاجتماعية المسؤولية الاجتماعية مدونة قواعد السلوك الخاصة | 27 https://www.avient.com/company/sustainability/sustainability-report http://Avient.com/sustainability سؤال: طلب منّيّ مشرفي المباشر اتّبّاع إجراء جديد للتخلص من النفايات إلا أنني غير متأكد من أن هذا الأمر آمنًاً أو حتى قانونيًاً.

OnCap Denesting Case Study-CN3.19-1 食品包装添加剂 解决发黏问题 Challe nge Accepted.

Mevopur Standard Colors Product Bulletin-CN3.26-1 MEVOPUR™ 着色剂 医疗应用的标准颜色 关键特性 监管支持 预先测试的原材料库，包括： - ISO 10993 - USP , (class VI) - USP - ICHQ3D 可提取金属 - EuPh 向FDA提交的DMF / MAF文档适用于所有标 准颜色 医疗应用 医疗设备，例如导管，手术和牙科器械或药 物输送设备 药物包装，包括药瓶或瓶子 血液分析诊断或体外诊断（IVD） 产品公告 & 色卡 MEVOPUR 着色剂解决方案组合专为当今日益复 杂的医疗保健应用而设计。

Evaluating a metal substitution involves two primary factors: 1) the difference in processing methodologies, and 2) the material capabilities. Though the upfront tooling costs can be high, the investment can yield a life expectancy of 100,000 to over 1 million cycles. https://www.avient.com/submit-a-design-engineering-question

��(( � 1 .( �1� $( �2 �� 34 ! ��(( � 1 .( �1� $( �2 �� 34 ! �� 7�� �1 � ( 3�&����'$� �* �1 ��$* �!

Das örtliche Avient-Unternehmen der Gerichtsbarkeit, bei dem Sie sich um eine Stelle bewerben, wird hinsichtlich Ihrer persönlichen Daten als Verantwortlicher der Datenverarbeitung fungieren. 1. Datum des Inkrafttretens: 1. August 2020 mailto:PRIVACY.OFFICER@AVIENT.COM https://privacyportal.onetrust.com/webform/b25cf7b1-a93a-4d26-8c84-ceda4d0ae91b/e180cbe4-d1b9-49bd-b621-cb5f6a0f42cb https://privacyportal.onetrust.com/webform/b25cf7b1-a93a-4d26-8c84-ceda4d0ae91b/e180cbe4-d1b9-49bd-b621-cb5f6a0f42cb mailto:PRIVACY.OFFICER@AVIENT.COM

The New PolyOne: A Specialty Growth Company Segment Highlights 16POLYONE CORPORATION 1.7% 4.6% 5.1% 5.5% 7.2% 8.1% 9.7% 12.2% 14.7% 16.7% 16.0% 2017 Revenue: $0.9 Billion United 46% 31% Asia 15% Latin South (27%) (14%) (10%) Textiles (12%) (8%) 15.5% Color, Additives & Inks 17POLYONE CORPORATION 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 8.6% 9.3% 12.1% 14.7% United 48% 28% 22% (20%) (19%) Electrical & Electronics (15%) (13%) (11%) 12.5% 2017 Revenue: $0.6 Billion Operating Income % of Sales 14.3% Specialty Engineered Materials 18POLYONE CORPORATION 5.5% 6.9% 3.8% 3.6% 5.5% 4.3% 6.3% 7.2% 7.7% 8.3% 12-14% 10.7% 11.1% United 77% 16% Latin 5% Building & Construction (30%) (16%) (15%) (18%) 2017 Revenue: $0.7 Billion Operating Income % of Sales Performance Products & Solutions 19POLYONE CORPORATION 23% 22% 18% 15% Appliance 7% E & E 6% B & C 3% W & C 38% ROIC* 2.6% 3.0% 3.5% 4.6% 5.6% 6.4% 5.9% 6.1% 6.6% 6.5 - 7.5%6.3% *After-Tax ROIC 6.4% 2017 Revenue: $1.2 Billion Key Suppliers 4.0% Distribution http://www.polyone.com/Pages/VariationRoot.aspx http://www.polyone.com/Pages/VariationRoot.aspx Target End Markets & Application Examples 21POLYONE CORPORATION Thermally Conductive Chemical Resistant Polymer Colorants Elastomeric Grips and Handles Structural Composites Antimicrobial Technologies Anti-Counterfeiting Target End Markets… Healthcare Catheter Technologies 22POLYONE CORPORATION Under-hood Components Target End Markets… Automotive Interior Structural Components Sound & Vibration Management Roof Systems Air Management Electronics and Cameras Lighting Exterior / Interior Trim Braces & Brackets Fasteners Seals & Flaps 23POLYONE CORPORATION Target End Markets… Consumer Thermally Conductive Components Polymer Colorants Elastomeric Grips and Handles Structural Composite Components 24POLYONE CORPORATION Oxygen Scavenger Laser Marking Additives Antistatic Technologies UV Light Barrier Technologies Cap & Closure Colorants Process Optimization Antioxidant Technologies Density Modified Technologies Target End Markets… Packaging 25POLYONE CORPORATION  Impart weight, sound and metallic finish to caps and closures for cosmetics and spirits applications  Elevate quality and prestige perceptions among high-end consumers  Eliminate time and cost associated with secondary operations and assembly Luxury Packaging GravitechTM Density Modified Polymers 26POLYONE CORPORATION Optimize Color Usage OnColorTM Super Concentrates  Eliminate costs by increasing pigment density  Enhance color performance without altering form and formulation  Increasing design capabilities by reducing weight and layer thickness 27POLYONE CORPORATION Combat Bacteria Formation WithStandTM Antimicrobial Technology  Inhibit microbial growth on polymer surfaces  Enhance value or products and devices  Highly versatile concentrate with the ability to be incorporated into a wide variety of products 28POLYONE CORPORATION Medical Device Housings Chemically Resistant Engineered Polymers  Durable, long-lasting products stand up to the most aggressive disinfectants  Minimize environmental stress cracking and discoloration  One of the broadest medically approved polymer and colorant portfolios 29POLYONE CORPORATION Color & Design Services  Greater control of color development and supply chain  Work across entire design process from concept to commercialization  Inspire creativity in the use of polymer materials, colors, and effects  Innovative brand differentiation  Faster development timelines 30POLYONE CORPORATION Outdoor Applications  Leading provider of high performance specialty materials for the recreational and sports & leisure industry  Well positioned across all segments to address market needs  Metal to Polymer Conversion  Lightweighting  Thermal Management  Impact Performance 31POLYONE CORPORATION  ColorMatrix Fiber Colorant  Proprietary advanced liquid color formulations and equipment enable greater efficiency and productivity  Eliminates aqueous dyeing and its associated wastewater treatment  Solid Color Concentrates  Extrusion-spun fibers colored via solid masterbatch Fiber Colorants 32POLYONE CORPORATION Smart Home Devices ResilienceTM Vinyl Solutions  High flame retardancy to meet strict UL standards  Greater processing and design flexibility  Specialized additives provide long term color stability  Diffusive lens materials improve light dispersion 1 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne common shareholders, adjusted earnings per share (EPS) attributable to PolyOne common shareholders and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance. Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016 2017 Net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — — — Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation 1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; the effect of changes in accounting principles or other such laws or provisions affecting reported results and tax adjustments.